Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Logan Kilpatrick has become the public face of Google's AI offensive, and, intentionally or not, a one-man marketing machine.

Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to ...

Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...

Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...

A public feud over model originality threatens China’s collaborative AI front, with Huawei denying whistleblower claims of ...

Computers can help ensure that mathematical proofs are correct, but translating traditional maths into a machine-readable ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

What L’Oréal and Microsoft’s AI strategies reveal about the future of beauty and marketing from empowering creators to ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

Colonialist accusations, trust issues, and not caring what Open AI is producing - AI ethicist Stephanie Antonian raises some ...